The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EXPRESS study: A trial exploring the association of low level of genomic alteration with exceptional and unexpected response to targeted therapies in patients with advanced solid tumors.
 
Olivia Le Saux
No Relationships to Disclose
 
Elodie Girard
No Relationships to Disclose
 
Lori Leslie
No Relationships to Disclose
 
Thomas Bachelot
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer; Seagen
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Novartis (Inst); Pfizer (Inst); SeaGen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; pfizer; Roche
 
Jean-Yves Pierga
Honoraria - Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); Novartis (Inst)
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Eisai Europe (Inst); Exact Sciences; Gilead Sciences; Lilly; Menarini Group; MSD Oncology; MSD Oncology (Inst); Novartis; Pfizer; Roche/Genentech; Roche/Genentech (Inst); Seagen; Veracyte
Research Funding - Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Pfizer
 
Fabrice Barlesi
Consulting or Advisory Role - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai Europe (Inst); Lilly (Inst); Merck Serono (Inst); Mirati Therapeutics (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Innate Pharma (Inst); Innate Pharma (Inst); Ipsen (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Laurence Albiges
Consulting or Advisory Role - Astellas Pharma (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; Ipsen; MSD; Pfizer
 
Celeste Lebbe
Honoraria - Amgen; Bristol-Myers Squibb; Incyte; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Inflax; Merck Serono; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Incyte; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Other Relationship - Avantis Medical Systems; BMS; InflaRx; Jazz Pharmaceuticals; MSD; Novartis; Pierre Fabre; Sanofi
 
Valerie Boige
No Relationships to Disclose
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); Clovis Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai; Exact Sciences (Inst); Gilead Sciences; GlaxoSmithKline; Lilly; MSD Oncology (Inst); Novartis (Inst); Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; seagen
 
Dominique Spaeth
No Relationships to Disclose
 
Aline Guillot
No Relationships to Disclose
 
Pierre Etienne Heudel
Stock and Other Ownership Interests - GEODAISICS
Honoraria - Amgen; AstraZeneca (Inst); Gilead Sciences; Mylan; Novartis (Inst); Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Lilly; Novartis (Inst); SEAGEN
Research Funding - Fresenius (Inst)
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Roche
 
Miriam Gardner
No Relationships to Disclose
 
Xavier Durando
No Relationships to Disclose
 
Julien Peron
Honoraria - Eisai Europe; Fab'entech
Research Funding - AstraZeneca/Merck (Inst)
 
Maud Kamal
No Relationships to Disclose
 
François Legrand
No Relationships to Disclose
 
Amelie Lusque
No Relationships to Disclose
 
Ivan Bieche
No Relationships to Disclose